Corporate action on climate change: perspectives on time, risk, and value by Metzner, M

Management accounting and decarbonization strategies by Mikes, A, Metzner, M

Lightening the carbon load: using management control systems to manage decarbonization strategies by Mikes, A, Metzner, M

How to measure performance in a purposeful company? Analysing the status quo by Stroehle, JC, Soonawalla, K, Metzner, M

Prozesssteuerung und Qualitätsmanagement in Tierkliniken durch Einsatz mobiler IT – Erfahrungsbericht aus einer Universitätstierklinik nach 5-jähriger Anwendung by Metzner, M., Gull, D., Gull, M., Stadler, O.

Get full text

Heterogeneous genetic and non-genetic mechanisms contribute to response and resistance to azacitidine monotherapy by Symeonidou, V, Metzner, M, Usukhbayar, B, Jackson, AE, Fox, S, Craddock, CF, Vyas, P

Mechanisms of response and resistance to AML therapies by Stoilova, B, Moore, R, Metzner, M, Zheng, Z, Konopleva, M, DiNardo, C, Vyas, P

Problematic use of prescription-type opioids prior to heroin use among young heroin injectors by Pollini RA, Banta-Green CJ, Cuevas-Mota J, Metzner M, Teshale E, Garfein RS

Get full text

Development of an Electronic Tool to Assess Patient Preferences in Geriatric Polypharmacy (PolyPref) by Eidam A, Roth A, Frick E, Metzner M, Lampert A, Seidling HM, Haefeli WE, Bauer JM

Get full text

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome by Cruz Hernandez, D, Metzner, M, de Groot, AP, Usukhbayar, B, Elliott, N, Roberts, I, Vyas, P

Molecular predictors of response to azacitidine therapy: the results of the UK trials acceleration programme RAVVA study by Craddock, C, Quek, L, Houlton, A, Ferguson, P, Gbandi, E, Roberts, C, Metzner, M, Wheatley, K, Siddique, S, Pillai, S, Dennis, M, Cavenagh, J, Vyas, P

A shared somatic translocation involving CUX1 in monozygotic twins as an early driver of AMKL in Down syndrome by Bache, I, Wadt, K, Mehrjouy, MM, Rossing, M, Østrup, O, Byrjalsen, A, Tommerup, N, Metzner, M, Vyas, P, Schmiegelow, K, Lausen, B, Andersen, MK

Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy by Loke, J, Metzner, M, Boucher, R, Jackson, A, Hopkins, L, Pavlu, J, Tholouli, E, Drummond, M, Peniket, A, Bishop, R, Fox, S, Vyas, P, Craddock, C

Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved by Aksöz, M, Gafencu, G-A, Stoilova, B, Buono, M, Zhang, Y, Turkalj, S, Meng, Y, Jakobsen, NA, Metzner, M, Clark, S-A, Beveridge, R, Thongjuea, S, Vyas, P, Nerlov, C

Phase Ib study of eltrombopag and azacitidine in patients with high-risk myelodysplastic syndromes and related disorders (the ELASTIC study) by Sternberg, A, Boucher, R, Coulthard, HC, Raghavan, M, Culligan, D, Jackson, A, Cargo, C, Dennis, M, Metzner, M, O'Sullivan, J, Moore, R, Bowen, D, Vyas, P

Most haematological abnormalities in neonates with Down syndrome are transient but dysplastic myelopoiesis persists throughout early childhood by Hanssen, L, Bhatnagar, N, Chaussade, A, Nizery, L, Elliott, N, Kennedy, A, Metzner, M, Norton, A, Hall, G, Vyas, P, Roberts, I, Oxford Down Syndrome Cohort Study Group

GTAC enables parallel genotyping of multiple genomic loci with chromatin accessibility profiling in single cells by Turkalj, S, Jakobsen, NA, Groom, A, Metzner, M, Riva, SG, Gür, ER, Usukhbayar, B, Salazar, MA, Hentges, LD, Mickute, G, Clark, K, Sopp, P, Davies, JOJ, Hughes, JR, Vyas, P

NGS IDENTIFIES MUTATIONS PROGNOSTIC OF RELAPSE AFTER ALLO-SCT AND NOVEL CLONE EMERGENCE AT DISEASE RECURRENCE: IMPLICATIONS FOR STRATEGIES TO PREVENT POST ALLO-SCT RELAPSE by Quek, L, Ferguson, P, Metzner, M, Ahmed, I, Garnett, C, Jeffries, S, Piechocki, K, Danby, R, Raghavan, M, Peniket, A, Griffiths, M, Bacon, A, Ward, J, Wheatley, K, Vyas, P, Craddock, C

Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology by Oakland, K, Chadwick, G, East, J, Guy, R, Humphries, A, Jairath, V, McPherson, S, Metzner, M, Morris, A, Murphy, M, Tham, T, Uberoi, R, Veitch, A, Wheeler, J, Regan, C, Hoare, J

Identification of 2 DNA methylation subtypes of Waldenström macroglobulinemia with plasma and memory B-cell features by Roos-Weil, D, Giacopelli, B, Armand, M, Della-Valle, V, Ghamlouch, H, Decaudin, C, Metzner, M, Lu, J, Le Garff-Tavernier, M, Leblond, V, Vyas, P, Zenz, T, Nguyen-Khac, F, Bernard, OA, Oakes, CC